Health risk assessment practices in the U.S. Food and Drug Administration

Regulatory Toxicology and Pharmacology

Volumn 26, Issue 3, 1997, Pages 307-321

  Gaylor, D W ^a   Axelrad, J A ^b   Brown, R P ^c   Cavagnaro, J A ^d   Cyr, W H ^c   Hulebak, K L ^e   Lorentzen, R J ^e   Miller, M A ^f   Mulligan, L T ^f   Schwetz, B A ^a,e  

^a National Center for Health Services Research   (United States)

^b Center for Drug Evaluation and Research   (United States)

^c Ctr Devices and Radiological Hlth   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f Center for Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CARCINOGEN; DRUG; FOOD ADDITIVE;

CANCER RISK; CONTROLLED STUDY; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; FOOD SAFETY; HEALTH HAZARD; HUMAN; POLICY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SAFETY; UNITED STATES;

ANIMALIA;

EID: 0031456528     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1997.1156     Document Type: Article

References (51)

1. Abdel-Rahman M. S., Kadry A. M. Studies on the use of uncertainty factors in deriving RFDs. Hum. Ecol. Risk Assess. 1:1995;614-624.
2. Ahn H., Kodell R. L. Estimation and testing of tumor incidence rates in experiments lacking cause-of-death data. Biometr. J. 37:1995;745-763.
3. Allen B. C., Crump K. S., Shipp A. M. Correlation between carcinogenic potency of chemicals in animals and humans. Risk Anal. 8:1988;531-544.
4. Barnes D. G., Dourson M. Reference dose (RfD): Description and use in health risk assessments. Regul. Toxicol. Pharmacol. 8:1988;471-486.
5. Bogen K. T. A note on compounded conservatism. Risk Anal. 14:1994;379-381.
6. Calabrese E. J., Baldwin L. A. A toxicological basis to derive generic interspecies uncertainty factors for application in human and ecological risk assessment. Hum. Ecol. Risk Assess. 1:1995;555-564.
7. Carrington C. D., Bolger P. M., Scheuplein R. J. Risk analysis of dietary lead exposure. Food Addit. Contam. 13:1996;61-76.
8. Chen J. J. A malformation incidence dose-response model incorporating fetal weight and/or litter size as covariates. Risk Anal. 13:1993;559-564.
9. Chen J. J., Kodell R. L. Quantitative risk assessment for teratological effects. J. Am. Stat. Asso. 84:1989;966-971.
10. Chen J. J., Kodell R. L., Gaylor D. W. Using the biological two-stage model to assess risk from short-term exposures. Risk Anal. 8:1988;223-230.
11. Chen J. J., Kodell R. L., Howe R. B., Gaylor D. W. Analysis of trinomial responses from reproductive and developmental toxicity experiments. Biometrics. 47:1991;1049-1058.
12. Crump K. S. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4:1984;854-871.
13. Crump K. S., Hoel D. G., Langley C. H., Peto R. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36:1976;2973-2979.
14. Farmer J. H., Kodell R. L., Gaylor D. W. Estimation and extrapolation of tumor probabilities from a mouse bioassay with survival/sacrifice components. Risk Anal. 2:1982;27-34.
15. W. G. Flamm, L. R. Lake, R. J. Lorentzen, A. M. Rulis, P. S. Schwartz, T. C. Troxell, 1987, Carcinogenic potencies and establishment of a threshold-of-regulation for food contact substances, Contemporary Issues in Risk Assessment, 2, Plenum, New York.
16. Gaylor D. W. Incidence of developmental defects at the no observed adverse effect level (NOAEL). Regul. Toxicol. Pharmacol. 15:1992;151-160.
17. Gaylor D. W., Chen J. J. A simple upper limit for the sum of the risks of the components in a mixture. Risk Anal. 16:1996;395-398.
18. Gaylor D. W., Chen J. J., Sheehan D. M. Uncertainty in cancer risk estimates. Risk Anal. 13:1993;149-154.
19. Gaylor D. W., Gold L. S. Quick estimate of the regulatory virtually safe dose based on the maximum tolerated dose for rodent bioassays. Regul. Toxicol. Pharmacol. 22:1995;57-63.
20. Gaylor D. W., Kodell R. L. Linear interpolation algorithm for low dose risk assessment of toxic substances. J. Environ. Pathol. Toxicol. 4:1980;305-312.
21. Gaylor D. W., Kodell R. L., Chen J. J., Springer J. A., Lorentzen R. J., Scheuplein R. J. Point estimates of cancer risk at low doses. Risk Anal. 14:1994;843-850.
22. Gaylor D. W., Slikker W. Risk assessment for neurotoxic effects. Neurotoxicology. 11:1990;211-218.
23. Gaylor D. W., Zheng Q. Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents. Risk Anal. 16:1996;221-225.
24. Kadry A. M., Skowronski G. A., Abdel-Rahman M. S. Evaluation of the use of uncertainty factors in deriving RfDs for some chlorinated compounds. J. Toxicol. Environ. Health. 45:1995;83-95.
25. Kodell R. L., Gaylor D. W., Chen J. J. Using average lifetime dose rate for intermittent exposures to carcinogens. Risk Anal. 7:1987;339-345.
26. Kodell R. L., Haskin M. G., Shaw G. W., Gaylor D. W. CHRONIC: A SAS procedure for statistical analysis of carcinogenesis studies. J. Statist. Comp. Simul. 16:1983;287-310.
27. Kodell R. L., Howe R. B., Chen J. J., Gaylor D. W. Mathematical modelling of reproductive and developmental toxic effects for quantitative risk assessment. Risk Anal. 11:1991a;583-590.
28. Kodell R. L., Krewski D., Zielinski J. M. Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis. Risk Anal. 11:1991b;483-490.
29. Kodell R. L., West R. W. Upper confidence limits on excess risk for quantitative responses. Risk Anal. 13:1993;177-182.
30. Lai D. Y. Perspective on alternative carcinogenicity testing design: Possible use of reduced protocols, mechanistic data and predictive techniques. Environ. Carcinogen. Ecotoxicol. Rev. C10:1992;121-140.
31. Lorentzen R. J. FDA procedures for carcinogenic risk assessment. Food Technol. 38:1984;108-111.
32. Lutz W. K., Gaylor D. W. Significance of DNA adducts at low dose: Shortening the time to spontaneous tumor occurrence. Regul. Toxicol. Pharmacol. 23:1996;29-34.
33. Moolgavkar S. H., Knudson A. G. Mutation and cancer: A model for human carcinogenesis. J. Natl. Cancer Inst. 66:1981;1037-1052.
34. Moolgavkar S. H., Venzon D. J. Two-event models for carcinogenesis: Incidence curves for childhood and adult tumors. Math. Biosci. 47:1979;55-77.
35. Peto R., Pike M. C., Day N. E., Gray R. G., Lee P. N., Parish S., Peto J., Richards S., Wahrendorf J. Guidelines for Simple, Sensitive Significance Tests for Carcinogenic Effects in Long-Term Animal Experiments: IARC Monographs. 1980;International Agency for Research on Cancer, Lyon.
36. A. M. Rulis, 1987, De minimus, Food Protection Technology, C. W. Felix, Lewis Publ. Inc. Chelsea, MI.
37. Rulis A. M. Establishing a threshold of regulation. Bonin J. J., Stevenson D. E. Risk Assessment in Setting National Priorities. 1989;271-278 Plenum, New York.
38. Rulis A. M. Threshold of regulation: Options for handling minimal risk situations. Finley, Robinson, Armstrong. Food Safety Assessment. Amer. Chem. Soc. Sympos. Series 484. 1992;132-139.
39. Slob W. Uncertainty analysis in multiplicative models. Risk Anal. 14:1994;571-576.
40. Turturro A., Duffy P. H., Hart R. W. Modulation for toxicity by diet and dietary macronutrient restriction. Mutat. Res. 295:1993;151-164.
41. Fed. Reg. 57:1992;24152-24173.
42. Fed. Reg. 61:April 23, 1996;17960-18011.
43. Fed. Reg. 47:Apr. 2, 1982;14464-14470.
44. Fed. Reg. 50:Oct. 31, 1985;45530-45556.
45. Fed. Reg. 52:Dec. 31, 1987;49572-49590.
46. Fed. Reg. 53:Aug. 30, 1988;33118.
47. Fed. Reg. 58:Oct. 12, 1993;52719-52729.
48. Fed. Reg. 60:July 17, 1995;36582-36596.
49. Fed. Reg. 61:Aug. 21, 1996;43298-43300.
50. Weil C. S., McCollister D. D. Relationship between short- and long-term feeding studies in designing an effective toxicity test. Agric. Food Chem. 11:1963;486-491.
51. Zheng Q. On the exact hazard and survival functions of the MVK stochastic carcinogenesis model. Risk Anal. 14:1994;1081-1084.